Globe Life
Sells basic life and supplemental health insurance through agency and direct-response channels.
Something off on this page? Send us feedback.
Profile
Sells basic life insurance and supplemental health coverage to lower-middle- and middle-income U.S. households through exclusive agents, independent agencies, and direct-response channels. Earnings come primarily from underwriting margins and investment income, with life insurance the largest margin contributor and agent recruiting central to agency growth.
Provides basic life insurance and supplemental health coverage, including Medicare Supplement, accident, cancer, and critical-illness policies, primarily to lower-middle- and middle-income households in the United States.
American Income Life, Liberty National, and Family Heritage distribute through exclusive independent agents; United American uses independent agencies, while Direct to Consumer markets through mail, digital media, and inbound phone channels. The mix combines local agency relationships with direct-response reach, and life insurance remains the largest source of underwriting margin.
Premiums and investment income fund policy benefits and operating costs, so results depend on underwriting assumptions, policy persistency, investment returns, and reserve adequacy. Agency growth depends on recruiting and retaining producing agents, and operations remain subject to state insurance regulation and exposure to agent-conduct and worker-classification claims.
Company facts
Categories
Key statistics
Year to date +24.8% · Average volume (30d) 621.8K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Jul 15, 2026 | Piper Sandler | Reiterate | Overweight | $175 | $200 |
| Jul 10, 2026 | Jefferies | Reiterate | Hold | $90 | $166 |
| May 26, 2026 | Piper Sandler | Reiterate | Overweight | $167 | $175 |
| May 21, 2026 | Morgan Stanley | Reiterate | Overweight | $176 | $181 |
| Apr 24, 2026 | Truist Financial | Target | $158 | $185 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026Q2 FY26 | $3.67 | $3.61 | −1.6% | $1.59B | $1.60B | +0.6% | −7.02% |
| Apr 22, 2026Q1 FY26 | $3.46 | $3.43 | −0.9% | $1.56B | $1.56B | −0.3% | +1.80% |
| Feb 4, 2026Q4 FY25 | $3.44 | $3.39 | −1.5% | $1.53B | $1.52B | −0.8% | +1.47% |
| Oct 22, 2025Q3 FY25 | $4.60 | $4.81 | +4.6% | $1.52B | $1.51B | −0.4% | +0.05% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.48B | $1.48B | $1.51B | $1.52B | $1.56B | $1.60B | |
| Gross profit | $459.8M | $456.5M | $624.8M | $462.6M | $770.0M | −$804.1M | |
| Operating income | $316.1M | $313.3M | $477.1M | $356.3M | $368.1M | −$629.6M | |
| Net income | $254.6M | $252.7M | $387.8M | $266.0M | $270.5M | $287.7M | |
| Diluted EPS | $3.01 | $3.05 | $4.71 | $3.29 | $3.45 | $3.65 | |
| Gross margin | 31.1% | 30.8% | 41.3% | 30.4% | 49.4% | -50.3% | |
| Operating margin | 21.4% | 21.2% | 31.5% | 23.4% | 23.6% | -39.4% |
Fiscal years (4-quarter sums)FY21 $5.12B · FY22 $5.21B · FY23 $5.22B · FY24 $5.78B · FY25 $6.00B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $455.4M · Total debt $2.94B · Total assets $31.56B · Shareholders' equity $6.16B
Dividends
Raised for 26 straight years — most recently to $0.33 from $0.27 in Apr 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jul 6, 2026 | Jul 6 | Jul 31 | $0.33 | |
| Apr 2, 2026 | Apr 3 | May 1 | $0.33 | raised from $0.27 |
| Jan 5, 2026 | Jan 5 | Jan 30 | $0.27 | |
| Oct 3, 2025 | Oct 3 | Oct 31 | $0.27 | |
| Jul 3, 2025 | Jul 3 | Aug 1 | $0.27 | |
| Apr 3, 2025 | Apr 3 | May 1 | $0.27 | raised from $0.24 |
| Jan 6, 2025 | Jan 6 | Jan 31 | $0.24 | |
| Oct 4, 2024 | Oct 4 | Nov 1 | $0.24 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 77.64M · Float 77.02M · 99.2% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.53M | 7.12% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 5.08M | 6.54% | 13F | Aug 13, 2026 |
| Wellington Investment Advisors Holdings LLP | 4.79M | 5.33% | 13G | Nov 8, 2024 |
| Invesco Ltd. | 4.62M | 5.95% | 13F | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 4.18M | 5.39% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 7, 2026 | Robert Brian Mitchell | officer: EVP, General Counsel and CRO | −23,000 | $183.34 |
| Jul 31, 2026 | James Matthew Darden | director, officer: Co-Chairman & CEO | −50,000 | $182.43 |
| Jul 29, 2026 | Michael Clay Majors | officer: EVP - Chief Strategy Officer | −37,000 | $178.64 |
| Jul 30, 2026 | Thomas Peter Kalmbach | officer: EVP & CFO | −21,000 | $180.06 |
| Jul 28, 2026 | Thomas Peter Kalmbach | officer: EVP & CFO | −25,650 | $178.58 |
Peers
- Primerica
Middle-income term life and agent distribution overlap
- CNO Financial Group
Middle-income life and supplemental health peer
- Aflac
Supplemental-health specialist with voluntary-benefits scale
- Unum Group
Workplace-benefits rival in life and supplemental coverage
- MetLife
Large group-benefits and life insurer with voluntary products
- Prudential Financial
Broad life and group-insurance competitor
- Lincoln Financial
Life and group-protection overlap, with supplemental health
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Globe Life | $172.79 | +0.05% | $13.42B | 11.4 | 10.4 | 2.2 | +8.0% |
| Primerica | $290.39 | +0.07% | $9.06B | 11.7 | 11.2 | 2.7 | +9.0% |
| CNO Financial Group | $57.00 | +2.96% | $5.17B | 19.0 | 11.7 | 1.1 | +11.6% |
| Aflac | $116.52 | −0.00% | $59.31B | 12.6 | 15.9 | 3.3 | −2.4% |
| Unum Group | $93.38 | +0.31% | $14.73B | 21.7 | 10.4 | 1.1 | −13.8% |
| MetLife | $97.91 | +1.46% | $62.10B | 18.5 | 9.2 | 0.8 | +10.0% |
| Prudential Financial | $119.79 | +0.01% | $41.57B | 10.8 | 8.5 | 0.6 | +2.8% |
| Lincoln Financial | $43.25 | −0.07% | $8.29B | 3.7 | 5.3 | 0.4 | +21.2% |
| Median | 12.6 | 10.4 | 1.1 | +9.0% |